Similar to iRGE, the targeting peptide CLKADKAKC (CK3) contains a potential CendR motif and has been studied for SPECT imaging of breast cancer, but no comparative analysis has been performed for the difference in tumor targeting ability between CK3 and iRGD (Feng et al., 2014). The gene discussed is KRT3; the disease is breast carcinoma.